TLV:GOHO

Golden House Ltd · TLV · Healthcare · ILS · FY for 2025

Figures on this page computed 2026-11-08 13:40 UTC

Last close

n/aILA

Market data

21.4xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
ILA
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
ILA
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
14.9%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
ILA
- Computed from the filing for 2025
- Computed from the filing for 2025
21.3%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
ILA
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
ILA
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
ILA
- computed

What it pays out is the furthest below its sector's middle: 0.07 against 0.54 on the market's range.

All from 100

lens 2 of 9

Sales

89.1

2016-12-31 to 2025-12-31100 at the start89.1

Sales: 100.00 on 2016-12-31 to 89.10 on 2025-12-31, down 11%.

Profit

62.9

2016-12-31 to 2025-12-31100 at the start62.9

Profit: 100.00 on 2016-12-31 to 62.93 on 2025-12-31, down 37%.

Shares in issue

107

2016-12-31 to 2025-12-31100 at the start107

Shares in issue: 100.00 on 2016-12-31 to 106.89 on 2025-12-31, up 7%.

Sales is at 89, Profit is at 63, Shares in issue is at 107, against 100 in 2016.

Sales is at 89, Profit is at 63, Shares in issue is at 107, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 10089
Source
computed
Statement
income
Fiscal year
2025
Reported in
ILS
Profit, where the first year is 10063
Source
computed
Statement
income
Fiscal year
2025
Reported in
ILS
Shares in issue, where the first year is 100107
Source
computed
Statement
income
Fiscal year
2025
Reported in
ILS